Anavex Life Sciences (12X1) Stock Forecast & Price Target
12X1 Analyst Ratings
There are no analyst ratings in the last 3 months.
12X1 Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
| Analyst Profile | Expert Firm | Price Target | Position | Upside / Downside | Action | Date | Follow | Article |
|---|---|---|---|---|---|---|---|---|
| Seema Sheoran | Rodman & Renshaw | EUR 17.85 | buy | 1603.06%Upside | Initiated | 05/04/26 | ||
| Ram Selvaraju | H.C. Wainwright | EUR 17.85 | buy | 1603.06%Upside | Reiterated | 03/31/26 |
| Analyst Profile | Date | Price Target | Position | Upside / Downside | Action | Follow | Article | Expert Firm |
|---|---|---|---|---|---|---|---|---|
| Seema Sheoran | 05/04/26 | EUR 17.85 | buy | 1603.06%Upside | Initiated | Rodman & Renshaw | ||
| Ram Selvaraju | 03/31/26 | EUR 17.85 | buy | 1603.06%Upside | Reiterated | H.C. Wainwright |
Best Analysts Covering Anavex Life Sciences
Copying Ram Selvaraju's trades and holding each position for 3 Months would result in 30.00% of your transactions generating a profit, with an average return of -19.43% per trade.
Copying Ram Selvaraju's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -68.38% per trade.
Copying Ram Selvaraju's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -75.74% per trade.
12X1 Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 2 | 1 | 0 | 0 | 0 |
In the current month, 12X1 has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 12X1 average Analyst price target in the past 3 months is ―.
12X1 Financial Forecast
12X1 Earnings Forecast
Next quarter’s earnings estimate for 12X1 is EUR 0.07 with a range of ― to ―. The previous quarter’s EPS was EUR 0.07. 12X1 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 12X1 has Performed in-line its overall industry.
12X1 Sales Forecast
Next quarter’s sales forecast for 12X1 is EUR 0 with a range of ― to ―. The previous quarter’s sales results were EUR 0. 12X1 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 12X1 has Performed in-line its overall industry.